Gastrointestinal Cancer News

The FDA cleared an investigational new drug application for a T-cell receptor therapy designed to treat adults with solid epithelial cancers that express Kita-Kyushu lung cancer antigen 1.

The American Gastroenterological Association published a conceptual model and clinical practice update for the prevention, detection and management of colorectal dysplasia in patients with inflammatory bowel disease.

Incidence of early-onset colorectal cancer has increased in the United States over the past 2 decades, but trends vary considerably by race and ethnicity, according to study results published in Clinical Gastroenterology and Hepatology.

The International Hepato-Pancreato-Biliary Association established consensus guidelines for liver transplantation among patients with nonresectable colorectal liver metastases.

The FDA cleared an investigational new drug application for GCC19CART, a chimeric antigen receptor T-cell therapy designed to treat patients with relapsed or refractory metastatic colorectal cancer.

The FDA granted orphan drug designation to gavo-cel for treatment of cholangiocarcinoma.

Treatment at high-volume radiation therapy facilities correlated with improved survival among select patients with common malignancies, according to study results published in Cancer.

Scientists have made amazing advances in recent years in understanding the molecular biology of cancer.

Use of antibiotics appeared consistently associated with higher subsequent risk for proximal colon cancer, according to results of a nationwide, population-based study published in Journal of the National Cancer Institute.

Patients were more likely to express preference for a same-sex endoscopy team member than a same-sex endoscopist, according to survey results published in the American Journal of Gastroenterology.